Baird Medical Investment Holdings (BDMD) Short term Debt (2023 - 2026)

Baird Medical Investment Holdings (BDMD) has reported Short term Debt for 4 consecutive years, with $1.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Short term Debt fell 48.24% year-over-year to $1.3 million in Q2 2026; TTM through Jun 2026 was $1.3 million, a 48.24% decrease from a year earlier, with the FY2025 full-year figure at $1.8 million, up 108.01% from the prior year.
• Short term Debt was $1.3 million for Q2 2026 at Baird Medical Investment Holdings, down from $1.8 million in the prior quarter.
• Over five years, Short term Debt peaked at $2.6 million in Q2 2025 and troughed at $817485.0 in Q4 2023.
• A 4-year average of $1.5 million and a median of $1.3 million in 2026 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt jumped 108.01% in 2025 and slumped 48.24% in 2026, its largest moves.
• Over 4 years, Short term Debt stood at $817485.0 in 2023, then grew by 6.15% to $867772.0 in 2024, then jumped by 108.01% to $1.8 million in 2025, then fell by 25.69% to $1.3 million in 2026.
• The last three Short term Debt figures came in at $1.3 million (Q2 2026), $1.8 million (Q4 2025), and $2.6 million (Q2 2025), per Business Quant data.